179 related articles for article (PubMed ID: 34298674)
1. Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells.
Matula Z; Mikala G; Lukácsi S; Matkó J; Kovács T; Monostori É; Uher F; Vályi-Nagy I
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298674
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells.
Matula Z; Uher F; Vályi-Nagy I; Mikala G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982377
[TBL] [Abstract][Full Text] [Related]
3. Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung.
Sinclair KA; Yerkovich ST; Hopkins PM; Chambers DC
Stem Cell Res Ther; 2016 Jul; 7(1):91. PubMed ID: 27406134
[TBL] [Abstract][Full Text] [Related]
4. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function.
Jorgensen C; Khoury M
Front Immunol; 2021; 12():606781. PubMed ID: 33763061
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage.
Li X; Zhang Y; Yeung SC; Liang Y; Liang X; Ding Y; Ip MS; Tse HF; Mak JC; Lian Q
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):455-65. PubMed ID: 24738760
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.
Maiso P; Mogollón P; Ocio EM; Garayoa M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067236
[TBL] [Abstract][Full Text] [Related]
7. Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.
Suzuki R; Ogiya D; Ogawa Y; Kawada H; Ando K
Curr Oncol; 2022 Nov; 29(11):8529-8539. PubMed ID: 36354732
[TBL] [Abstract][Full Text] [Related]
8. CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma.
Marlein CR; Piddock RE; Mistry JJ; Zaitseva L; Hellmich C; Horton RH; Zhou Z; Auger MJ; Bowles KM; Rushworth SA
Cancer Res; 2019 May; 79(9):2285-2297. PubMed ID: 30622116
[TBL] [Abstract][Full Text] [Related]
9. Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple Myeloma.
Boise LH; Shanmugam M
Cancer Res; 2019 May; 79(9):2102-2103. PubMed ID: 31043428
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy.
Mohammadalipour A; Dumbali SP; Wenzel PL
Front Cell Dev Biol; 2020; 8():603292. PubMed ID: 33365311
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model.
Han H; Hu J; Yan Q; Zhu J; Zhu Z; Chen Y; Sun J; Zhang R
Mol Med Rep; 2016 Feb; 13(2):1517-24. PubMed ID: 26718099
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial transfer from bone-marrow-derived mesenchymal stromal cells to chondrocytes protects against cartilage degenerative mitochondrial dysfunction in rats chondrocytes.
Wang R; Maimaitijuma T; Ma YY; Jiao Y; Cao YP
Chin Med J (Engl); 2020 Aug; 134(2):212-218. PubMed ID: 32858593
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview.
Barbato A; Scandura G; Puglisi F; Cambria D; La Spina E; Palumbo GA; Lazzarino G; Tibullo D; Di Raimondo F; Giallongo C; Romano A
Front Oncol; 2020; 10():604143. PubMed ID: 33409153
[TBL] [Abstract][Full Text] [Related]
15. Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
Plesner T; van de Donk N; Richardson PG
Cells; 2020 Feb; 9(2):. PubMed ID: 32041300
[TBL] [Abstract][Full Text] [Related]
16. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
[TBL] [Abstract][Full Text] [Related]
17. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria transfer from mesenchymal stem cells structurally and functionally repairs renal proximal tubular epithelial cells in diabetic nephropathy in vivo.
Konari N; Nagaishi K; Kikuchi S; Fujimiya M
Sci Rep; 2019 Mar; 9(1):5184. PubMed ID: 30914727
[TBL] [Abstract][Full Text] [Related]
19. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells.
Cai J; Wang J; Huang Y; Wu H; Xia T; Xiao J; Chen X; Li H; Qiu Y; Wang Y; Wang T; Xia H; Zhang Q; Xiang AP
Cell Death Dis; 2016 Nov; 7(11):e2459. PubMed ID: 27831567
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Ria R; Vacca A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
